What is the recommended cefixime dose for uncomplicated typhoid fever in adults and children, and how should it be adjusted for renal impairment or resistant infections?

Cefixime Dosing for Typhoid Fever

For uncomplicated typhoid fever, cefixime should be dosed at 20 mg/kg/day orally divided into two doses (maximum 400 mg twice daily) for 7-14 days in children, and 400 mg daily (as a single dose or divided) for 7-14 days in adults.

Pediatric Dosing

Children (≥6 months): The recommended dose is 20 mg/kg/day divided into two doses (10 mg/kg every 12 hours) for 7-14 days 1. The WHO Pocket Book recommends ceftriaxone (not cefixime) as second-line for typhoid at 80 mg/kg/day for 5-7 days, but clinical trials have established cefixime dosing at 20 mg/kg/day 2, 3.

For practical administration using oral suspension:

• Weight-based dosing: Use the FDA-approved weight-band dosing chart 4
• Children >45 kg or >12 years: Use adult dose of 400 mg daily 4

Important caveat: Cefixime suspension achieves higher peak blood levels than tablets at the same dose, so tablets should not be substituted for suspension in children 4.

Adult Dosing

Adults: 400 mg daily (can be given as single daily dose or divided) for 7-14 days 4. The FDA label approves 400 mg daily as the standard adult dose 4.

Duration of Therapy

The optimal duration is 7-14 days. Clinical trials have used:

• 7 days: Minimum effective duration 5
• 12-14 days: Standard duration in most trials 2, 3

Recommendation: Use 14 days for multidrug-resistant (MDR) typhoid to ensure adequate treatment and minimize relapse risk 2, 3.

Renal Impairment Adjustments

For adults with renal dysfunction 4:

• CrCl ≥60 mL/min: Normal dose (400 mg daily)
• CrCl 21-59 mL/min or hemodialysis: 260 mg daily (13 mL of 100 mg/5 mL suspension or 6.5 mL of 200 mg/5 mL suspension)
• CrCl ≤20 mL/min or peritoneal dialysis: 172 mg daily (8.6 mL of 100 mg/5 mL suspension or 4.4 mL of 200 mg/5 mL suspension)

Neither hemodialysis nor peritoneal dialysis removes significant amounts of cefixime 4.

Comparative Effectiveness and Resistance Considerations

Critical limitation: Cefixime performs significantly worse than fluoroquinolones for typhoid fever. In head-to-head trials, cefixime showed:

• Increased clinical failure: RR 13.39 (95% CI 3.24-55.39) 6
• Longer fever clearance time: Mean 8.5 days vs 4.4 days with ofloxacin 5
• Higher relapse rates: RR 4.45 (95% CI 1.11-17.84) 6

When to use cefixime:

• Fluoroquinolone-resistant typhoid (nalidixic acid-resistant strains)
• Contraindications to fluoroquinolones (pregnancy, children where fluoroquinolones avoided)
• Mild-to-moderate illness in outpatient settings

When NOT to use cefixime:

• Severe/complicated typhoid fever (use IV ceftriaxone instead)
• Extensively drug-resistant (XDR) typhoid (requires azithromycin ± meropenem) 7
• If fluoroquinolone-susceptible strains and no contraindications exist

Alternative Regimens

Ceftriaxone (IV) is superior to oral cefixime for:

• Severe illness
• Inability to tolerate oral medications
• Dose: 80 mg/kg/day IV (maximum 2-4 g/day) for 5-7 days 1

Azithromycin may be superior to cefixime:

• Dose: 20 mg/kg/day (maximum 1 g/day) for 5-7 days 1
• Shorter fever clearance time (5.8 days) compared to cefixime (7.1 days) 8
• Clinical cure rate: 85% vs 71% with cefixime 8

Common Pitfalls

1. Underdosing in children: Ensure 20 mg/kg/day, not the lower 8 mg/kg/day used for other infections 2
2. Inadequate duration: Minimum 7 days; 14 days preferred for MDR strains to prevent relapse 2, 3
3. Using tablets in young children: Suspension provides better bioavailability 4
4. Ignoring local resistance patterns: Cefixime effectiveness depends on local susceptibility 7, 6
5. Not adjusting for renal impairment: Dose reduction required for CrCl <60 mL/min 4